The second Datathon training took place in Brest together with the project SC meeting (4-5 October 2017). 23 researchers participated in this event kindly organized by Jacques-Oliver Pers from UBO.Read more →
Esta web utiliza cookies propias y de terceros para mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí.
PRECISESADS http://www.precisesads.eu/, an IMI funded project, has now recruited over 2000 people into its pan-European cross sectional clinical study of systemic autoimmune diseases such as rheumatoid arthritis and lupus. This milestone means that the project is well on track towards its goal of recruiting a total of 2 500 people from across 9 European countries.Read more →
The latest PRECISESADS meeting took place on the 7-10th of March 2017 at SERVIER`s headquarters in PARIS. This 4 days event started with the Datathon training, organised by Jérôme Wojcik (WP8), that had as a main objective to perform clustering analyses of Cross-Sectional phase 1 data, allowing different partners to work together and exchange codeRead more →
PRECISESADS http://www.precisesads.eu/, an IMI funded project, has now recruited over 2 000 people into its pan-European clinical study on systemic autoimmune diseases such as rheumatoid arthritis and lupus. This milestone means that the project is well on track towards its final goal of recruiting a total of 2 500 people from across 9 different countries.Read more →
This website reflects only the author’s views and neither IMI nor the European Commission are liable for any use that may be made of the information contained therein.
PRECISESADS receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° , resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases